Physician profile
John Thometz
NPI 1386165389
$10,630.57
in general payments reported to CMS, 2019-2025
25 companies · $2,731 in 2025
The $2,731 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $756 · 2021: $837 · 2022: $2,192 · 2023: $2,170 · 2024: $1,823 · 2025: $2,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,723.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,245.37 | 2020-2025 | Ortholoc 2 Lapifuse, Citrefix, 7 X 23mm Citrelock Implant |
| Kerecis Limited | $2,617.05 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Surgenex LLC | $931.96 | 2025 | Pellograft, Renograft, Surgraft |
| Convatec INC. | $698.81 | 2023-2024 | |
| Abbott Laboratories | $503.34 | 2022-2023 | Proclaim |
| Treace Medical Concepts, INC. | $492.21 | 2023-2025 | |
| Organogenesis INC. | $431.49 | 2020-2025 | Puraply Wound Matrix, Apligraf |
| Medtronic, INC. | $250.56 | 2021-2022 | |
| Smith+Nephew, INC. | $202.32 | 2019-2025 | Stravix Pl, Collagenase Santyl |
| Depuy Synthes Sales INC. | $193.57 | 2022-2023 | Motoband |
| Miach Orthopaedics, INC. | $183.28 | 2024 | |
| Linvatec Corporation | $155.20 | 2024 | Biobrace 23mm, Fracture and Correction Colag 2 |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Baudax Bio INC. | $108.01 | 2020 | |
| Horizon Therapeutics Plc | $98.10 | 2020-2023 | Krystexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $86.45 | 2023 | Acumed, Osteomed |
| Paragon 28, INC. | $63.42 | 2023-2025 | Phantom Metatarsal Shortening, Tenotac, Activcore Nail |
| Medela LLC | $56.50 | 2021 | |
| Flower Orthopedics Coporation | $43.08 | 2025 | |
| Amgen INC. | $38.34 | 2024-2025 | Krystexxa |
| Osteomed LLC | $28.00 | 2021 | |
| Aroa Biosurgery Incorporated | $24.57 | 2023 | |
| Paratek Pharmaceuticals, INC. | $23.00 | 2025 | Nuzyra |
| Ethicon US, LLC | $22.89 | 2022 | |
| Nevro Corp. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thometz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.